ARCHIVES

CMS To Begin National Coverage Analysis Of Provenge

This article is from The Cancer Letter archive.

Vol. 36 No. 25 | July 2, 2010

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Kaposi Study, Blocks Monitoring Plan

February 26, 1982

ACCC Seeks Greater Role In Clinical Research Priorities; Suggests Up To 400 Cancer Program

April 13, 1979

NCI Cooperative Group, Cancer Center Trials Listed

July 27, 2007

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Senate Democrats Include $1 Billion Boost To NIH In Economic Stimulus Package.

November 21, 2008

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002